[go: up one dir, main page]

FR3078609B1 - COMPOSITION FOR DECREASING GLUTEN SENSITIVITY - Google Patents

COMPOSITION FOR DECREASING GLUTEN SENSITIVITY Download PDF

Info

Publication number
FR3078609B1
FR3078609B1 FR1870246A FR1870246A FR3078609B1 FR 3078609 B1 FR3078609 B1 FR 3078609B1 FR 1870246 A FR1870246 A FR 1870246A FR 1870246 A FR1870246 A FR 1870246A FR 3078609 B1 FR3078609 B1 FR 3078609B1
Authority
FR
France
Prior art keywords
composition
decreasing
gluten sensitivity
gluten
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1870246A
Other languages
French (fr)
Other versions
FR3078609A1 (en
Inventor
Jean-Yves Thebaudin
Colette LARRE
Roberta Lupi
Maxime Perot
Pascale Gadonna-Widehem
Pauline Anton
Carine Delayre-Orthez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abcd Nutrition
Original Assignee
Abcd Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abcd Nutrition filed Critical Abcd Nutrition
Priority to FR1870246A priority Critical patent/FR3078609B1/en
Publication of FR3078609A1 publication Critical patent/FR3078609A1/en
Application granted granted Critical
Publication of FR3078609B1 publication Critical patent/FR3078609B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'objet de l'invention est une composition adaptée à une administration par voie orale comprenant : - au moins un prébiotique, - au moins une souche de bactéries probiotiques, - au moins une levure probiotique, et - au moins un polyphénol. Cette composition est particulièrement utile pour diminuer la réactivité au gluten de personnes intolérantes ou sensibles.The subject of the invention is a composition suitable for oral administration comprising: - at least one prebiotic, - at least one strain of probiotic bacteria, - at least one probiotic yeast, and - at least one polyphenol. This composition is particularly useful for reducing the gluten reactivity of intolerant or sensitive people.

FR1870246A 2018-03-08 2018-03-08 COMPOSITION FOR DECREASING GLUTEN SENSITIVITY Active FR3078609B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1870246A FR3078609B1 (en) 2018-03-08 2018-03-08 COMPOSITION FOR DECREASING GLUTEN SENSITIVITY

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1870246 2018-03-08
FR1870246A FR3078609B1 (en) 2018-03-08 2018-03-08 COMPOSITION FOR DECREASING GLUTEN SENSITIVITY

Publications (2)

Publication Number Publication Date
FR3078609A1 FR3078609A1 (en) 2019-09-13
FR3078609B1 true FR3078609B1 (en) 2020-02-21

Family

ID=63442700

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1870246A Active FR3078609B1 (en) 2018-03-08 2018-03-08 COMPOSITION FOR DECREASING GLUTEN SENSITIVITY

Country Status (1)

Country Link
FR (1) FR3078609B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
IT1392672B1 (en) * 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A COMPOSITIONS INCLUDING PROBIOTIC COMPONENTS AND PREBIOTICS AND MINERAL SALTS, WITH LACTOFERRINA
FR3001633B1 (en) * 2013-02-04 2017-02-24 Laboratoires Inneov COSMETIC COMBINATION OF NUTRITIONAL ASSETS TO MAINTAIN A GOOD STATE OF THE SKIN AND TO PROMOTE LOSS OF WEIGHT
FR3030253B1 (en) * 2014-12-18 2018-03-02 Nutricos Technologies COMPOSITION FOR IMPROVING THE CELLULAR ASPECT OF THE SKIN

Also Published As

Publication number Publication date
FR3078609A1 (en) 2019-09-13

Similar Documents

Publication Publication Date Title
WO2018158306A8 (en) Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
EP3873442A4 (en) MANUAL ADMINISTRATION OF BUTYRATE, BETA-HYDROXYBUTYRATE, CANNABIDIOL AND RELATED COMPOUNDS
EP3823986A4 (en) USE OF ANTIBODIES DIRECTED AGAINST SEQUENCE FAMILY 19, ELEMENT A5, FOR THE TREATMENT OF NEUROPATHIC PAIN
EP4420724A3 (en) Edaravone suspension for oral administration
WO2021021837A3 (en) Anti-pvrig antibodies formulations and uses thereof
BR112022018549A2 (en) INNOVATIVE COMPOUNDS USEFUL IN THE TREATMENT AND/OR PREVENTION OF AN ANGIOTENSIN II DISEASE, DISORDER OR CONDITION
EP3846616A4 (en) CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS
WO2023004415A3 (en) Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments
FR3086168A3 (en) TRAVEL MINI ELEVATOR FOR DISABLED PEOPLE
FR3078609B1 (en) COMPOSITION FOR DECREASING GLUTEN SENSITIVITY
BR112022008384A2 (en) ORAL FORMULATION OF X842
EP4093337A4 (en) DUAL MOBILITY REVERSE CUP SHOULDER PROSTHESIS
FR3083981B1 (en) COMPOSITIONS FOR COSMETIC AND DERMATOLOGICAL USE
MX2022004912A (en) NEW REPLACED CONDENSED RING COMPOUND.
AR123001A1 (en) ANTI-NOTCH2 ANTIBODIES AND METHODS OF USE
MX2021012146A (en) VAGINAL TABLET FORMULATION.
EP4230652A4 (en) ANTI-OSCAR ANTIBODIES FOR THE PREVENTION OR TREATMENT OF OSTEOARTHRITIS
EP3829559A4 (en) HISTONE DEACETYLASE INHIBITORS USEFUL FOR THE TREATMENT OR PREVENTION OF HIV INFECTION
MA53707A (en) INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION
FR3078610B1 (en) COMPOSITION OF SPECIAL PROBIOTICS AND USE FOR REDUCING DIGESTIVE INFLAMMATORY SYMPTOMS
CL2022001355A1 (en) Methods for treating-preventing idiopathic pneumonia syndrome, capillary leak syndrome, engraftment syndrome and-or fluid overload
MX2018013031A (en) USE OF AN ACETILCOLINESTERASE AND IDALOPIRDINE INHIBITOR TO REDUCE FALLS IN PATIENTS WITH PARKINSON'S DISEASE.
FR2868318B1 (en) ANTIGEN STABILIZED TAT AND ITS APPLICATIONS FOR ANTI-HIV VACCINATION
FR3074752B1 (en) HINGE FOR AIRBAG FLAP
FR3038617B1 (en) USE OF CEREAL PROCESSING BY-PRODUCTS FOR THE PREPARATION OF A PROTEIN ENRICHED COMPOSITION COMPRISING YEAST

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190913

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8